chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: fever of 100.2F; bad headache; tiredness; achiness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achiness), PYREXIA (fever of 100.2F), HEADACHE (bad headache) and FATIGUE (tiredness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PAIN (achiness). 14-Apr-2021, the patient experienced FATIGUE (tiredness). On 15-Apr-2021, the patient experienced PYREXIA (fever of 100.2F). 15-Apr-2021, the patient experienced HEADACHE (bad headache). At the time of the report, PAIN (achiness) and FATIGUE (tiredness) outcome was unknown and PYREXIA (fever of 100.2F) and HEADACHE (bad headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication provided.  No treatment drugs were provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable     This case was linked to US-MODERNATX, INC.-MOD-2021-077705 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077705:1st dose
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Nausea, Pyrexia
Clinical narrative: Fever of 100; chills; nausea; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100), CHILLS (chills), NAUSEA (nausea) and ARTHRALGIA (joint pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042b21a) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder.    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PYREXIA (Fever of 100), CHILLS (chills), NAUSEA (nausea) and ARTHRALGIA (joint pain). At the time of the report, PYREXIA (Fever of 100), CHILLS (chills), NAUSEA (nausea) and ARTHRALGIA (joint pain) outcome was unknown. Not Provided          No Concomitant medication were reported. Treatment medication was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dizziness, Headache, Tinnitus, Vaccination site swelling
Clinical narrative: Lower back pain ("kidney pain" ); ringing on the left ear (feels like there is air swishing inside); dizziness; severe throbbing headache/pressure; left arm (site of injection) became swollen; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (Lower back pain ("kidney pain" )), TINNITUS (ringing on the left ear (feels like there is air swishing inside)), DIZZINESS (dizziness), HEADACHE (severe throbbing headache/pressure) and VACCINATION SITE SWELLING (left arm (site of injection) became swollen) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020. Concurrent medical conditions included Low back pain in May 2020.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced BACK PAIN (Lower back pain ("kidney pain" )), TINNITUS (ringing on the left ear (feels like there is air swishing inside)), DIZZINESS (dizziness), HEADACHE (severe throbbing headache/pressure) and VACCINATION SITE SWELLING (left arm (site of injection) became swollen). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and MECLIZINE [MECLOZINE] at an unspecified dose and frequency. At the time of the report, BACK PAIN (Lower back pain ("kidney pain" )), TINNITUS (ringing on the left ear (feels like there is air swishing inside)), DIZZINESS (dizziness), HEADACHE (severe throbbing headache/pressure) and VACCINATION SITE SWELLING (left arm (site of injection) became swollen) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Treatment medication included, Aspirin, Tylenol. On 11Apr2021, she went to the emergency room and was given Toradol injection for the headache and Meclizine for the dizziness and Pseudo tripolidine.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable     This case was linked to MOD-2021-077669 (E2B Linked Report).; Sender's Comments:  MOD-2021-077669:First Dose
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Fever blisters all over his lips; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (Fever blisters all over his lips) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ORAL HERPES (Fever blisters all over his lips). At the time of the report, ORAL HERPES (Fever blisters all over his lips) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  The patient had some kind of imbalance occurs in body.  No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pain
Clinical narrative: pains; extreme fatigue; extreme headache, like a migraine; aches; joint pain in knees and hips; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pains), FATIGUE (extreme fatigue), HEADACHE (extreme headache, like a migraine), MYALGIA (aches) and ARTHRALGIA (joint pain in knees and hips) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 026B21A) for COVID-19 vaccination.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), VITAMIN B NOS, MAGNESIUM and VITAMINS NOS for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PAIN (pains), FATIGUE (extreme fatigue), HEADACHE (extreme headache, like a migraine), MYALGIA (aches) and ARTHRALGIA (joint pain in knees and hips). At the time of the report, PAIN (pains), FATIGUE (extreme fatigue), HEADACHE (extreme headache, like a migraine), MYALGIA (aches) and ARTHRALGIA (joint pain in knees and hips) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported   This case was linked to MOD21-076332, MOD21-076420 (E2B Linked Report).; Sender's Comments:  MOD21-076332:Husband report MOD21-076420:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: it is all swollen; it is all red; injection site itches like crazy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itches like crazy), VACCINATION SITE SWELLING (it is all swollen) and VACCINATION SITE ERYTHEMA (it is all red) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itches like crazy). On 15-Apr-2021, the patient experienced VACCINATION SITE SWELLING (it is all swollen) and VACCINATION SITE ERYTHEMA (it is all red). At the time of the report, VACCINATION SITE PRURITUS (injection site itches like crazy), VACCINATION SITE SWELLING (it is all swollen) and VACCINATION SITE ERYTHEMA (it is all red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Vomiting
Clinical narrative: feeling horrible; hold on a second I'm going to go throw up; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling horrible) and VOMITING (hold on a second I'm going to go throw up) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced FEELING ABNORMAL (feeling horrible) and VOMITING (hold on a second I'm going to go throw up). At the time of the report, FEELING ABNORMAL (feeling horrible) and VOMITING (hold on a second I'm going to go throw up) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: over 6 weeks beyond the recommended dosing interval; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (over 6 weeks beyond the recommended dosing interval) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (over 6 weeks beyond the recommended dosing interval). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (over 6 weeks beyond the recommended dosing interval) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications and treatment information were reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Patient is past 42 days of dosing interval; This spontaneous case was reported by a health care professional and describes the occurrence of OFF LABEL USE (Patient is past 42 days of dosing interval) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Patient is past 42 days of dosing interval). At the time of the report, OFF LABEL USE (Patient is past 42 days of dosing interval) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications and treatment information were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Product administration interrupted, Product availability issue
Clinical narrative: 1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame; 1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame) and PRODUCT AVAILABILITY ISSUE (1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Previously administered products included for an unreported indication: COVID-19 VACCINE (Patient received 1st dose intramuscularly in left deltoid muscle (Batch: 027620A)) on 29-Jan-2021.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame) and PRODUCT AVAILABILITY ISSUE (1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame) and PRODUCT AVAILABILITY ISSUE (1st dose given 29Jan2021, because facility closed down, second dose not schedule til 24April2021, going to schedule second vaccine outside the 35 day time frame) outcome was unknown. Not Provided          No Treatment information was reported.   This case was linked to MOD21-076258 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Patient Birth date, Previous COVID-19 vaccine dose details added, event verbatim information updated; Sender's Comments:  MOD21-076258:Birth date of patient and verbatim updated
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling abnormal, Headache, Nausea
Clinical narrative: Feeling of fogginess; Dizzy; Fever of 102.0; Nausea; Vomiting; Chills; Moderate headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling of fogginess), DIZZINESS (Dizzy), PYREXIA (Fever of 102.0), NAUSEA (Nausea) and VOMITING (Vomiting) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling of fogginess), DIZZINESS (Dizzy), PYREXIA (Fever of 102.0), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Moderate headache). At the time of the report, FEELING ABNORMAL (Feeling of fogginess), DIZZINESS (Dizzy), PYREXIA (Fever of 102.0), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Moderate headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Feeling of fogginess; Dizzy; Fever of 102.0; Nausea; Vomiting; Chills; Moderate headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling of fogginess), DIZZINESS (Dizzy), PYREXIA (Fever of 102.0), NAUSEA (Nausea) and VOMITING (Vomiting) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Feeling of fogginess), DIZZINESS (Dizzy), PYREXIA (Fever of 102.0), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Moderate headache). At the time of the report, FEELING ABNORMAL (Feeling of fogginess), DIZZINESS (Dizzy), PYREXIA (Fever of 102.0), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Moderate headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness). At the time of the report, FATIGUE (tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous
Clinical narrative: Red rash; itchy; rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021 and was forwarded to Moderna on 15-Apr-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of RASH ERYTHEMATOUS (Red rash), PRURITUS (itchy) and RASH (rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and LEVOCETIRIZINE for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), PRURITUS (itchy) and RASH (rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat). At the time of the report, RASH ERYTHEMATOUS (Red rash), PRURITUS (itchy) and RASH (rash all over his body-buttocks, legs, thighs, back and chest/some rash areas raised and some areas are flat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Headache, Pain in extremity
Clinical narrative: weakness; pain in his left arm; stomach ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), PAIN IN EXTREMITY (pain in his left arm), ABDOMINAL PAIN UPPER (stomach ache) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced ASTHENIA (weakness), PAIN IN EXTREMITY (pain in his left arm), ABDOMINAL PAIN UPPER (stomach ache) and HEADACHE (headache). On 07-Apr-2021, ASTHENIA (weakness), PAIN IN EXTREMITY (pain in his left arm), ABDOMINAL PAIN UPPER (stomach ache) and HEADACHE (headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received and does not contain any new information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: achiness in the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (achiness in the injection arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced INJECTION SITE PAIN (achiness in the injection arm). At the time of the report, INJECTION SITE PAIN (achiness in the injection arm) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant medications were provided  No treatment medications were provided   This case was linked to, INC.-MOD-2021-077686 (E2B Linked Report).; Sender's Comments:  , INC.-MOD-2021-077686:2nd dose
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: left work early today as he just felt a little unsteady; dizzy; a lot of muscle aches; slight fever, 99.5, unusual for him; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him), HEADACHE (headache) and FATIGUE (left work early today as he just felt a little unsteady) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure, Diuretic effect, Blood sugar abnormal and COVID-19 in February 2021.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him) and HEADACHE (headache). On 15-Apr-2021, the patient experienced FATIGUE (left work early today as he just felt a little unsteady). At the time of the report, DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him), HEADACHE (headache) and FATIGUE (left work early today as he just felt a little unsteady) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 99.5 degree Celsius (High) 99.5 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The other relevant concomitant medication were reported as Blood Pressure medication, Diuretics and Blood sugar medications.  No treatment information was reported.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: left work early today as he just felt a little unsteady; dizzy; a lot of muscle aches; slight fever, 99.5, unusual for him; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him), HEADACHE (headache) and FATIGUE (left work early today as he just felt a little unsteady) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure, Diuretic effect, Blood sugar abnormal and COVID-19 in February 2021.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him) and HEADACHE (headache). On 15-Apr-2021, the patient experienced FATIGUE (left work early today as he just felt a little unsteady). At the time of the report, DIZZINESS (dizzy), MYALGIA (a lot of muscle aches), PYREXIA (slight fever, 99.5, unusual for him), HEADACHE (headache) and FATIGUE (left work early today as he just felt a little unsteady) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Body temperature: 99.5 degree Celsius (High) 99.5 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The other relevant concomitant medication were reported as Blood Pressure medication, Diuretics and Blood sugar medications.  No treatment information was reported.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Atrial flutter, Chest discomfort, Cough, Feeling hot
Clinical narrative: palpitations; flutter; Pressure on the Chest but not Chest pain; Hot Body during Palpitation & Flutter; loss of taste; coughing; fast heart beat; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), ATRIAL FLUTTER (flutter), CHEST DISCOMFORT (Pressure on the Chest but not Chest pain), AGEUSIA (loss of taste) and COUGH (coughing) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2020, the patient experienced AGEUSIA (loss of taste), COUGH (coughing) and HEART RATE INCREASED (fast heart beat). On 06-Apr-2021, the patient experienced PALPITATIONS (palpitations), ATRIAL FLUTTER (flutter), CHEST DISCOMFORT (Pressure on the Chest but not Chest pain) and FEELING HOT (Hot Body during Palpitation & Flutter). At the time of the report, PALPITATIONS (palpitations), ATRIAL FLUTTER (flutter), CHEST DISCOMFORT (Pressure on the Chest but not Chest pain), AGEUSIA (loss of taste), COUGH (coughing), HEART RATE INCREASED (fast heart beat) and FEELING HOT (Hot Body during Palpitation & Flutter) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   In March2020, patient mention that she was sick with COVID-19 symptoms and went to the ER but they did not test her for COVID they told her she did not meet criteria. In March2020 she had loss of taste, coughing and more. She had heart palpitations and heart fluttering back then and she had fast heartbeat as well. It all eventually went away. She never did an antibody test to see if she had COVID from last year.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Palpitations
Clinical narrative: palpitations; flutter; Pressure on the Chest but not Chest pain; Hot Body during Palpitation & Flutter; loss of taste; coughing; fast heart beat; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), ATRIAL FLUTTER (flutter), CHEST DISCOMFORT (Pressure on the Chest but not Chest pain), AGEUSIA (loss of taste) and COUGH (coughing) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL for an unknown indication.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2020, the patient experienced AGEUSIA (loss of taste), COUGH (coughing) and HEART RATE INCREASED (fast heart beat). On 06-Apr-2021, the patient experienced PALPITATIONS (palpitations), ATRIAL FLUTTER (flutter), CHEST DISCOMFORT (Pressure on the Chest but not Chest pain) and FEELING HOT (Hot Body during Palpitation & Flutter). At the time of the report, PALPITATIONS (palpitations), ATRIAL FLUTTER (flutter), CHEST DISCOMFORT (Pressure on the Chest but not Chest pain), AGEUSIA (loss of taste), COUGH (coughing), HEART RATE INCREASED (fast heart beat) and FEELING HOT (Hot Body during Palpitation & Flutter) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   In March2020, patient mention that she was sick with COVID-19 symptoms and went to the ER but they did not test her for COVID they told her she did not meet criteria. In March2020 she had loss of taste, coughing and more. She had heart palpitations and heart fluttering back then and she had fast heartbeat as well. It all eventually went away. She never did an antibody test to see if she had COVID from last year.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Lymphadenopathy, Vaccination site pain
Clinical narrative: toes felt like they were on fire; swollen right gland in throat after taking the first dose; aching after taking the first dose in the right arm; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (toes felt like they were on fire), LYMPHADENOPATHY (swollen right gland in throat after taking the first dose) and VACCINATION SITE PAIN (aching after taking the first dose in the right arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis. Concomitant products included LANSOPRAZOLE (PREVACID) and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced BURNING SENSATION (toes felt like they were on fire), LYMPHADENOPATHY (swollen right gland in throat after taking the first dose) and VACCINATION SITE PAIN (aching after taking the first dose in the right arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (toes felt like they were on fire), LYMPHADENOPATHY (swollen right gland in throat after taking the first dose) and VACCINATION SITE PAIN (aching after taking the first dose in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Fatigue, Pain
Clinical narrative: Felt a very deep ache throughout entitre body; Tired; Every bone in  body hurt; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Every bone in  body hurt), PAIN (Felt a very deep ache throughout entitre body) and FATIGUE (Tired) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic back pain (2 major back surgeries.), Hypothyroidism, Scleroderma (Autoimmune disease.), Pustular psoriasis (Autoimmune disease.) and Drug allergy (Allergic to penicillin, e-mycin, Compazine, dynastat, breo.). Concomitant products included LEVOTHYROXINE, MORPHINE SULFATE, PREGABALIN, TIMOLOL, LATANOPROST, KETOROLAC, VITAMIN C [ASCORBIC ACID], CALCIUM and MINERALS NOS, VITAMINS NOS (CENTRUM BALANCE) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced BONE PAIN (Every bone in  body hurt). On 05-Feb-2021, the patient experienced PAIN (Felt a very deep ache throughout entitre body) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 05-Feb-2021, BONE PAIN (Every bone in  body hurt) had resolved. At the time of the report, PAIN (Felt a very deep ache throughout entitre body) and FATIGUE (Tired) had resolved. Not Provided          Treatment information included Blood pressure medication and  took Tylenol throughout the day evening, every 4 hours plus. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.   This case was linked to MOD-2021-005455, US-MODERNATX, INC.-MOD-2021-005455 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-May-2021 updated patient address, demographics, concomitant medications and add events.; Sender's Comments:  MOD-2021-005455:1st dose of vaccine US-MODERNATX, INC.-MOD-2021-005455:DOSE 2
Sex: F
Vaccine: COVID19
Symptoms: Tooth infection
Clinical narrative: Tooth infection; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH INFECTION (Tooth infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TOOTH INFECTION (Tooth infection). At the time of the report, TOOTH INFECTION (Tooth infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications and treatment information were reported.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Depilation, Headache, Lip swelling, Myalgia
Clinical narrative: body ache; headache; swollen lip(filler in lip); sensitivity (hurts) where has derma filler; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body ache), HEADACHE (headache), LIP SWELLING (swollen lip(filler in lip)) and DEPILATION (sensitivity (hurts) where has derma filler) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body ache), HEADACHE (headache), LIP SWELLING (swollen lip(filler in lip)) and DEPILATION (sensitivity (hurts) where has derma filler). At the time of the report, MYALGIA (body ache), HEADACHE (headache), LIP SWELLING (swollen lip(filler in lip)) and DEPILATION (sensitivity (hurts) where has derma filler) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment medication was not given.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Chills, Cough, Disturbance in attention
Clinical narrative: can not go to work or focus properly; covid 19; Fever; chills; cough; Muscle aches; insomnia,Unbale to sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (insomnia,Unbale to sleep), DISTURBANCE IN ATTENTION (can not go to work or focus properly), COVID-19 (covid 19), PYREXIA (Fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Right bundle branch block.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 10-Jan-2021, the patient experienced INSOMNIA (insomnia,Unbale to sleep), COVID-19 (covid 19), PYREXIA (Fever), CHILLS (chills), COUGH (cough) and MYALGIA (Muscle aches). On an unknown date, the patient experienced DISTURBANCE IN ATTENTION (can not go to work or focus properly). On 28-Apr-2021, COVID-19 (covid 19) had resolved. At the time of the report, INSOMNIA (insomnia,Unbale to sleep) and DISTURBANCE IN ATTENTION (can not go to work or focus properly) had not resolved and PYREXIA (Fever), CHILLS (chills), COUGH (cough) and MYALGIA (Muscle aches) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, Body temperature: 100.4 High. On 10-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 28-Apr-2021, SARS-CoV-2 test: negative (Negative) Negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       No concomitant medications were provided Patient treated his symptoms with melatonin and other sleep-aid   This case was linked to US-MODERNATX, INC.-MOD-2021-077749 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow up information received on 17-MAY-2021, added medical history and lab data , added events , updated action taken (N/A) , updated event outcome; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077749:Second dose case
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: can not go to work or focus properly; covid 19; Fever; chills; cough; Muscle aches; insomnia,Unbale to sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (insomnia,Unbale to sleep), DISTURBANCE IN ATTENTION (can not go to work or focus properly), COVID-19 (covid 19), PYREXIA (Fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Right bundle branch block.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 10-Jan-2021, the patient experienced INSOMNIA (insomnia,Unbale to sleep), COVID-19 (covid 19), PYREXIA (Fever), CHILLS (chills), COUGH (cough) and MYALGIA (Muscle aches). On an unknown date, the patient experienced DISTURBANCE IN ATTENTION (can not go to work or focus properly). On 28-Apr-2021, COVID-19 (covid 19) had resolved. At the time of the report, INSOMNIA (insomnia,Unbale to sleep) and DISTURBANCE IN ATTENTION (can not go to work or focus properly) had not resolved and PYREXIA (Fever), CHILLS (chills), COUGH (cough) and MYALGIA (Muscle aches) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Jan-2021, Body temperature: 100.4 High. On 10-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. On 28-Apr-2021, SARS-CoV-2 test: negative (Negative) Negative.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       No concomitant medications were provided Patient treated his symptoms with melatonin and other sleep-aid   This case was linked to US-MODERNATX, INC.-MOD-2021-077749 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow up information received on 17-MAY-2021, added medical history and lab data , added events , updated action taken (N/A) , updated event outcome; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077749:Second dose case
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (achy). At the time of the report, PAIN (achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. no concomitant medications are provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nasal congestion, Sinus congestion, Sneezing, Throat irritation
Clinical narrative: Sneezing; Nose is stuffed up, Congestion in the head; Scratchy throat; she feels like she is under the weather; Nose is stuffed up; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), SINUS CONGESTION (Nose is stuffed up, Congestion in the head), THROAT IRRITATION (Scratchy throat), FEELING ABNORMAL (she feels like she is under the weather) and NASAL CONGESTION (Nose is stuffed up) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension. Concomitant products included INSULIN HUMAN INJECTION, ISOPHANE (HUMULIN N) for Diabetes, LOSARTAN for Hypertension.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced SNEEZING (Sneezing), SINUS CONGESTION (Nose is stuffed up, Congestion in the head), THROAT IRRITATION (Scratchy throat), FEELING ABNORMAL (she feels like she is under the weather) and NASAL CONGESTION (Nose is stuffed up). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, SNEEZING (Sneezing), SINUS CONGESTION (Nose is stuffed up, Congestion in the head), THROAT IRRITATION (Scratchy throat), FEELING ABNORMAL (she feels like she is under the weather) and NASAL CONGESTION (Nose is stuffed up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Sneezing
Clinical narrative: cold; Sneezing; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (cold) and SNEEZING (Sneezing) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced NASOPHARYNGITIS (cold) and SNEEZING (Sneezing). At the time of the report, NASOPHARYNGITIS (cold) and SNEEZING (Sneezing) outcome was unknown. Not Provided          No concomitant medications were reported.  Treatment information was not provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: tines on chest (feels there something in there); sore arm; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tines on chest (feels there something in there)), PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and MYALGIA (body aches) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 031A21A) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN B COMPLEX and MAGNESIUM for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Apr-2021 at 8:00 PM, the patient experienced PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and MYALGIA (body aches). On 15-Apr-2021, the patient experienced CHEST DISCOMFORT (tines on chest (feels there something in there)). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (tines on chest (feels there something in there)), PAIN IN EXTREMITY (sore arm), PYREXIA (fever) and MYALGIA (body aches) outcome was unknown. Not Provided          Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant medications also include unspecified birth control medication.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: increased her heart rate; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (increased her heart rate) in a 19-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced HEART RATE INCREASED (increased her heart rate). On 06-Apr-2021, HEART RATE INCREASED (increased her heart rate) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medications included patient was given some medication but unable to remember correct medicine given by doctor.